These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1850405)

  • 41. Tumor necrosis factor expression in human epithelial tumor cell lines.
    Spriggs DR; Imamura K; Rodriguez C; Sariban E; Kufe DW
    J Clin Invest; 1988 Feb; 81(2):455-60. PubMed ID: 2828427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin 1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation.
    Saklatvala J; Guesdon F
    J Rheumatol Suppl; 1992 Jan; 32():65-9; discussion 69-70. PubMed ID: 1319489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A decade of accumulated knowledge and emerging answers. The 6th international congress on TNF Rhodes, Greece. May 1996.
    Wallach D
    Eur Cytokine Netw; 1996 Dec; 7(4):713-24. PubMed ID: 9010673
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of neutrophil adherence on the characteristics of receptors for tumor necrosis factor-alpha.
    Chamba A; Stockley RA; Burnett D
    FEBS Lett; 1991 May; 282(2):373-6. PubMed ID: 1645285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of tumor necrosis factor alpha (TNF-alpha) to high-affinity receptors on polymorphonuclear cells.
    Pichyangkul S; Schick D; Jia FL; Berent S; Bollon A; Kahn A
    Exp Hematol; 1987 Nov; 15(10):1055-9. PubMed ID: 2822458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism.
    Cheng N; Chen J
    J Biol Chem; 2001 Apr; 276(17):13771-7. PubMed ID: 11278471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene.
    Pocsik E; Higuchi M; Aggarwal BB
    Lymphokine Cytokine Res; 1992 Dec; 11(6):317-25. PubMed ID: 1335762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand.
    Imamura K; Spriggs D; Kufe D
    J Immunol; 1987 Nov; 139(9):2989-92. PubMed ID: 2822800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The biology of cachectin/TNF--a primary mediator of the host response.
    Beutler B; Cerami A
    Annu Rev Immunol; 1989; 7():625-55. PubMed ID: 2540776
    [No Abstract]   [Full Text] [Related]  

  • 50. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
    Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
    Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two distinct tumour necrosis factor receptors--members of a new cytokine receptor gene family.
    Loetscher H; Brockhaus M; Dembic Z; Gentz R; Gubler U; Hohmann HP; Lahm HW; Van Loon AP; Pan YC; Schlaeger EJ
    Oxf Surv Eukaryot Genes; 1991; 7():119-42. PubMed ID: 1661597
    [No Abstract]   [Full Text] [Related]  

  • 52. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.
    Engelmann H; Novick D; Wallach D
    J Biol Chem; 1990 Jan; 265(3):1531-6. PubMed ID: 2153136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell cycle specificity of tumor necrosis factor and its receptor.
    Watanabe N; Niitsu Y; Yamauchi N; Neda H; Sone H; Maeda M; Urushizaki I
    Cell Biol Int Rep; 1987 Nov; 11(11):813-7. PubMed ID: 2826017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor necrosis factor family ligand-receptor binding.
    Zhang G
    Curr Opin Struct Biol; 2004 Apr; 14(2):154-60. PubMed ID: 15093829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor alpha.
    Grazioli L; Alzani R; Ciomei M; Mariani M; Restivo A; Cozzi E; Marcucci F
    Int J Immunopharmacol; 1992 May; 14(4):637-42. PubMed ID: 1325955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein.
    Himmler A; Maurer-Fogy I; Krönke M; Scheurich P; Pfizenmaier K; Lantz M; Olsson I; Hauptmann R; Stratowa C; Adolf GR
    DNA Cell Biol; 1990 Dec; 9(10):705-15. PubMed ID: 1702293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding.
    Hohmann HP; Remy R; Pöschl B; van Loon AP
    J Biol Chem; 1990 Sep; 265(25):15183-8. PubMed ID: 2168404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice.
    Schreyer SA; Vick CM; LeBoeuf RC
    J Biol Chem; 2002 Apr; 277(14):12364-8. PubMed ID: 11809756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The TNF receptor super family in immune regulation.
    Ware CF
    Immunol Rev; 2011 Nov; 244(1):5-8. PubMed ID: 22017427
    [No Abstract]   [Full Text] [Related]  

  • 60. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.